QBNK have been invited to The Nordic Microscopy Society och a three-day conference in Finland in June
QBNK recently introduced its new heading into medicinal technologies through a collabroation with UC Davis. QBank will be used as a technical platform in order to carry out advanced image analysis within the research frame as well as manage research material faster and more efficient than ever before.
Business in this new area now picks up speed as QBNK have been invited to The Nordic Microscopy Society och the three-day conference SCANDEM in Finland June 9-11. Current guests include the majority of potential collaboration partners within this new business area, giving QBNK a good start on marketing the new medicine-technological solution.
- This invitations gives us a flying start and the best possible opportunity to market our new direction towards global users of Microscopy. We estimate a great market value of this sector, says Carl Petruson, CEO of QBNK.
The Nordic Microscopy Society is an organization that focuses on all aspects related to microscopy. This includes developments of the technology, specimen preparation techniques, applications in material and life sciences and new types of microscopy. Most of the members, more than 300 in 2012, come from universities, research institutes and industries in the Nordic countries. In order to spread the knowledge of microscopy arount the world, the society coordinates a number of events, among them the annual conference SCANDEM.
More information can be found at www.scandem.org
QBank's mission is to provide companies and government agencies cloud-based products and services in Digital Asset Management. The company has seen an annual 30-40% growth the last four years.
The ticker symbol for the stock is: QBNK
ISIN code of the company's shares is: SE0005934023
For more information, please contact:
Carl Petruson, CEO
QBNK Holding AB (publ)
Tel: +46 8-459 99 90
e-mail: carl.petruson@qbank.se